"Kula, Roman" . "Diferenci\u00E1ln\u00ED diagnostika trombocytopenie u kriticky nemocn\u00FDch pacient\u016F"@cs . "RIV/00843989:_____/10:00101285!RIV11-MZ0-00843989" . "U mnoh\u00FDch kriticky nemocn\u00FDch pacient\u016F se rozvinou poruchy hemost\u00E1zy po\u010D\u00EDnaje izolovanou trombocytopeni\u00ED a komplexn\u00EDmi defekty typu diseminovan\u00E9 intravaskul\u00E1rn\u00ED koagulace kon\u010De. Nov\u011B vznikl\u00E1 trombocytopenie a multiorg\u00E1nov\u00E9 selh\u00E1n\u00ED p\u0159edikuje \u0161patn\u00FD v\u00FDsledek. Pokles desti\u010Dek u kriticky nemocn\u00E9ho \u010Dlov\u011Bka m\u00E1 mnoho r\u016Fzn\u00FDch p\u0159\u00ED\u010Din a ka\u017Ed\u00E1 z nich m\u016F\u017Ee vy\u017Eadovat specifick\u00FD typ l\u00E9\u010Debn\u00E9 a podp\u016Frn\u00E9 p\u00E9\u010De. V posledn\u00EDch letech se m\u011Bn\u00ED pohled na patogenezi a klinick\u00FD p\u0159\u00EDstup k \u0159e\u0161en\u00ED mnoh\u00FDch poruch hemost\u00E1zy kriticky nemocn\u00FDch pacient\u016F. Nov\u00E9 poznatky pom\u00E1haj\u00ED ur\u010Dit optim\u00E1ln\u00ED diagnostickou a diferenci\u00E1ln\u011B diagnostickou strategii."@cs . . . "4"^^ . "V" . "U mnoh\u00FDch kriticky nemocn\u00FDch pacient\u016F se rozvinou poruchy hemost\u00E1zy po\u010D\u00EDnaje izolovanou trombocytopeni\u00ED a komplexn\u00EDmi defekty typu diseminovan\u00E9 intravaskul\u00E1rn\u00ED koagulace kon\u010De. Nov\u011B vznikl\u00E1 trombocytopenie a multiorg\u00E1nov\u00E9 selh\u00E1n\u00ED p\u0159edikuje \u0161patn\u00FD v\u00FDsledek. Pokles desti\u010Dek u kriticky nemocn\u00E9ho \u010Dlov\u011Bka m\u00E1 mnoho r\u016Fzn\u00FDch p\u0159\u00ED\u010Din a ka\u017Ed\u00E1 z nich m\u016F\u017Ee vy\u017Eadovat specifick\u00FD typ l\u00E9\u010Debn\u00E9 a podp\u016Frn\u00E9 p\u00E9\u010De. V posledn\u00EDch letech se m\u011Bn\u00ED pohled na patogenezi a klinick\u00FD p\u0159\u00EDstup k \u0159e\u0161en\u00ED mnoh\u00FDch poruch hemost\u00E1zy kriticky nemocn\u00FDch pacient\u016F. Nov\u00E9 poznatky pom\u00E1haj\u00ED ur\u010Dit optim\u00E1ln\u00ED diagnostickou a diferenci\u00E1ln\u011B diagnostickou strategii." . . . "Gumulec, Jarom\u00EDr" . . . "0042-773X" . . "5"^^ . . "Diferenci\u00E1ln\u00ED diagnostika trombocytopenie u kriticky nemocn\u00FDch pacient\u016F"@cs . . "thrombocytopenia; shock; sepsis; disseminated intravascular coagulation; drug-induced thrombocytopenia; immune thrombocytopenia; intensive care unit"@en . . "RIV/00843989:_____/10:00101285" . "Pleva, Leopold" . "254338" . . "Diferenci\u00E1ln\u00ED diagnostika trombocytopenie u kriticky nemocn\u00FDch pacient\u016F" . "56" . "Vnit\u0159n\u00ED l\u00E9ka\u0159stv\u00ED" . . . "\u0160imetka, Ond\u0159ej" . . "Differential diagnosis of thrombocytopaenia in critically ill patients"@en . "CZ - \u010Cesk\u00E1 republika" . . . "Diferenci\u00E1ln\u00ED diagnostika trombocytopenie u kriticky nemocn\u00FDch pacient\u016F" . "[7D8C4BC95AB5]" . "Many critically ill patients develop hemostatic abnormalities, ranging from isolated thrombocytopenia to complex defects, such as disseminated intravascular coagulation. New onset thrombocytopenia and multiple organ failure predicts poor outcome in critical illness. There are many causes for platelet count decline in critically ill patients and each of these may require specific therapeutic and supportive management. In recent years, new insights into the pathogenesis and clinical management of many hemostatic defects in critically ill patients have been accumulated and this knowledge is helpful in determining the optimal diagnostic and differential diagnostic strategy."@en . "Differential diagnosis of thrombocytopaenia in critically ill patients"@en . . . . . "Ullrychov\u00E1, J." . "13"^^ . "Suppl.1" . .